Overview
Background
I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.
I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.
I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, Griffith University
Research interests
-
Economic Evaluation of Healthcare Interventions
-
Health Technology Assessment
-
Value-Based Health Care
-
Cancer Economics
-
Medications use and safety
Research impacts
My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.
I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.
Works
Search Professor Haitham Tuffaha’s works on UQ eSpace
2023
Journal Article
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies
Modi, Natansh D., Kichenadasse, Ganessan, Hoffmann, Tammy C., Haseloff, Mark, Logan, Jessica M., Veroniki, Areti A., Venchiarutti, Rebecca L., Smit, Amelia K., Tuffaha, Haitham, Jayasekara, Harindra, Manning-Bennet, Arkady, Morton, Erin, McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J. and Hopkins, Ashley M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21 (1) 400, 400. doi: 10.1186/s12916-023-03113-0
2023
Conference Publication
Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer
Wang, Yufan, McCarthy, Alexandra L. and Tuffaha, Haitham (2023). Cost-Utility Analysis Of A Supervised Exercise Intervention For Women With Early-Stage Endometrial Cancer. HTAi 2023 Meeting, Adelaide, SA Australia, 24-28 June 2023. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/s0266462323001277
2023
Journal Article
A narrative review of health status and healthcare delivery in the oil and gas industry: impacts on employees, employers, and local communities
Fox, Jordan L., Gurney, Tiana, Kondalsamy-Chennakesavan, Srinivas, Pols, Thomas A. H., Tuffaha, Haitham, Pak, Anton and McGrail, Matthew (2023). A narrative review of health status and healthcare delivery in the oil and gas industry: impacts on employees, employers, and local communities. Healthcare, 11 (21) 2888, 1-17. doi: 10.3390/healthcare11212888
2023
Other Outputs
(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.
Edmunds, K., Hettiarachchi, R., Teppala, S., Shiksha, A., Madeline, O. and Tuffaha, H. (2023). (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
2023
Journal Article
Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer
Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Schreiber, Veronika, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron E. (2023). Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology, 83 (4), 647-656. doi: 10.1111/his.15000
2023
Other Outputs
(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.
Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
2023
Other Outputs
(August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.
Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
2023
Other Outputs
(August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.
Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.
2023
Journal Article
Economic evaluation of exercise interventions for individuals with cancer: a systematic review
Wang, Yufan, McCarthy, Alexandra L., Hayes, Sandra C., Gordon, Louisa G., Chiu, Vivian, Bailey, Tom G., Stewart, Elizabeth and Tuffaha, Haitham (2023). Economic evaluation of exercise interventions for individuals with cancer: a systematic review. Preventive Medicine, 172 107491, 1-8. doi: 10.1016/j.ypmed.2023.107491
2023
Conference Publication
Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol of an effectiveness-implementation hybrid (Type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials)
Green, Anna, Newton, Robert U., Chambers, Suzanne K., Smith, David P., Tuffaha, Haitham, Galvao, Daniel A., Heathcote, Peter, Patel, Manish, Christie, David, Egger, Sam, Sara, Sally, Heneka, Nicole and Dunn, Jeff (2023). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol of an effectiveness-implementation hybrid (Type 1) randomised trial of a tele-based nurse-led survivorship care intervention (PCEssentials). 2023 ANZUP Annual Scientific Meeting, Melbourne, VIC, Australia, 9‐11 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13976
2023
Journal Article
Tele-dentistry, its trends, scope, and future framework in oral medicine; a scoping review during January 1999 to December 2021
Niknam, Fatemeh, Sharifian, Roxana, Bashiri, Azadeh, Mardani, Maryam, Akbari, Reza, Tuffaha, Haitham, Do, Loc and Bastani, Peivand (2023). Tele-dentistry, its trends, scope, and future framework in oral medicine; a scoping review during January 1999 to December 2021. Archives of Public Health, 81 (1) 104, 1-14. doi: 10.1186/s13690-023-01128-w
2023
Journal Article
Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer
Wang, Yufan, McCarthy, Alexandra L and Tuffaha, Haitham (2023). Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer. Supportive Care in Cancer, 31 (7) 391, 391. doi: 10.1007/s00520-023-07819-y
2023
Conference Publication
HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases
Gough, Madeline, Liu, Cheng, Srinivasan, Bhuvana, Wilkinson, Lisa, Dunk, Louisa, Yang, Yuanhao, Tuffaha, Haitham, Kryza, Thomas, Hooper, John D., Lakhani, Sunil R. and Snell, Cameron Edward (2023). HER2 in situ hybridization testing in breast cancer: applying algorithm-assisted assessment to reduce interobserver variability in difficult cases. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e13561
2023
Other Outputs
(April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT
Hettiarachchi, R. and Tuffaha, H. (2023). (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT. Canberra, ACT, Australia: Commonwealth of Australia.
2023
Journal Article
Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway
Delaforce, Alana, Farmer, Shannon, Duff, Jed, Munday, Judy, Miller, Kristin, Glover, Lynne, Corney, Chris, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham, Hardy, Janet and Hurst, Cameron (2023). Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway. Transfusion, 63 (4), 724-736. doi: 10.1111/trf.17287
2023
Journal Article
A review of the cost-effectiveness of genetic testing for germline variants in familial cancer
Teppala, Srinivas, Hodgkinson, Brent, Hayes, Sandi, Scuffham, Paul and Tuffaha, Haitham (2023). A review of the cost-effectiveness of genetic testing for germline variants in familial cancer. Journal of Medical Economics, 26 (1), 19-33. doi: 10.1080/13696998.2022.2152233
2022
Journal Article
Approaches to prioritising research for clinical trial networks: a scoping review
Morton, Rachael L., Tuffaha, Haitham, Blaya-Novakova, Vendula, Spencer, Jenean, Hawley, Carmel M., Peyton, Phil, Higgins, Alisa, Marsh, Julie, Taylor, William J., Huckson, Sue, Sillett, Amy, Schneemann, Kieran, Balagurunanthan, Anitha, Cumpston, Miranda, Scuffham, Paul A., Glasziou, Paul and Simes, Robert J. (2022). Approaches to prioritising research for clinical trial networks: a scoping review. Trials, 23 (1) 1000, 1-21. doi: 10.1186/s13063-022-06928-z
2022
Conference Publication
How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL
Tuffaha, H., Arora, S., Denehy, L. and Edbrooke, L. (2022). How would the choice of the multi-attribute utility instrument affect the cost-effectiveness of cancer interventions? A comparison of the FACT-8D and the AQoL. ISPOR Europe 2022, Vienna, Austria, 6-9 November 2022. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2022.09.2001
2022
Conference Publication
How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?
Tuffaha, Haitham, Arora, Shiksha, Denehy, Linda and Edbrooke, Lara (2022). How would the choice of health-related quality of life measure affect the cost-effectiveness of oncology interventions?. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2022
Conference Publication
Genetic testing in prostate cancer: a scoping literature review
Edmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
Funding
Current funding
Supervision
Availability
- Professor Haitham Tuffaha is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program
Principal Advisor
Other advisors: Associate Professor Adam La Caze, Dr Kim Edmunds
Completed supervision
-
2024
Doctor Philosophy
Assessing the Value for Money of Integrating Exercise as Therapy after Gynaecological Cancer Treatment
Principal Advisor
Other advisors: Professor Sandie McCarthy
Media
Enquiries
Contact Professor Haitham Tuffaha directly for media enquiries about:
- Cancer Economics
- Health Economics
- Health Services Research
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: